Loading...
XHKG0557
Market cap29mUSD
Nov 06, Last price  
0.58HKD
Name

China Tian Yuan Healthcare Group Ltd

Chart & Performance

D1W1MN
XHKG:0557 chart
P/E
—
P/S
5.12
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-23.40%
Revenues
45m
-16.57%
72,147,00084,518,00079,010,000105,254,000122,479,00065,270,00083,686,000109,336,000135,085,000102,838,000100,130,00092,207,000100,654,000175,280,000171,556,00070,548,00056,340,00094,588,00054,216,00045,230,000
Net income
-15m
L-59.73%
26,519,0005,392,00095,452,00014,091,000-138,991,00055,865,0008,994,000-31,231,0007,064,00017,169,000-18,978,000-55,067,000-57,550,000-1,428,000-40,047,000-190,024,000-110,035,000-22,121,000-38,452,000-15,484,000
CFO
5m
P
6,981,00011,857,0003,142,00033,755,0005,985,0006,188,000-12,652,000-28,932,000-8,396,00020,488,000-14,410,000-15,974,000-30,666,000-157,301,000-95,562,000-116,784,00049,537,00016,317,000-30,362,0005,102,000
Dividend
Apr 14, 20080.03 HKD/sh

Profile

China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery services, as well as licenses trademarks. It also invests in equity investments and marketable equitable equity mutual funds; offers loans and related services; introduces lenders and borrowers; and provides procurement services to hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
URL
http://www.tianyuanhealthcare.com
IPO date
Dec 29, 1989
Employees
111
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
45,230
-16.57%
54,216
-42.68%
Cost of revenue
67,877
76,024
Unusual Expense (Income)
NOPBT
(22,647)
(21,808)
NOPBT Margin
Operating Taxes
(1,821)
(1,897)
Tax Rate
NOPAT
(20,826)
(19,911)
Net income
(15,484)
-59.73%
(38,452)
73.83%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,318
4,065
Long-term debt
87,494
98,191
Deferred revenue
Other long-term liabilities
227
Net debt
53,598
68,593
Cash flow
Cash from operating activities
5,102
(30,362)
CAPEX
(595)
(1,348)
Cash from investing activities
364
(1,233)
Cash from financing activities
(8,765)
(12,487)
FCF
130,888
(34,348)
Balance
Cash
26,734
31,603
Long term investments
11,480
2,060
Excess cash
35,952
30,952
Stockholders' equity
191,050
221,359
Invested Capital
225,134
262,262
ROIC
ROCE
EV
Common stock shares outstanding
398,980
398,980
Price
Market cap
EV
EBITDA
(13,571)
(12,279)
EV/EBITDA
Interest
3,543
3,959
Interest/NOPBT